Seqens and Novonesis Unite to Revolutionize Biocatalysis in Fine Chemicals

Seqens Group, a global leader in specialty and personal care ingredients, has announced a strategic partnership with Novonesis, a pioneer in sustainable biological solutions, to advance biocatalytic processes within the fine chemicals sector.

This collaboration leverages the strengths of both companies. Seqens’s Protéus teams bring deep expertise in enzyme discovery, optimization, and implementation of biocatalytic processes. On the other hand, Novonesis contributes with its massive strain bank, broad enzyme portfolio, and cutting-edge large-scale production capabilities aimed at replacing traditional chemical and metal catalysts with greener, more efficient enzyme-driven solutions.

Together, the two companies aim to provide comprehensive enzyme screening and streamlined biocatalytic process development. Seqens’s robust global manufacturing infrastructure ensures efficient delivery of custom process books and reaction products to customers worldwide.

“This unique partnership finally brings together two industry leaders to deliver innovative and competitive biocatalytic processes,” said Julien Boutet, Innovation & Biotechnologies Director at Seqens. Hans Ole Klingenberg of Novonesis added, “Together, we are accelerating the fine chemical industry’s shift toward sustainability and innovation.”

The partnership marks a pivotal step in driving eco-efficient industrial solutions, delivering high performance while reducing environmental impact.